AngioDynamics has announced it has completed its acquisition of Navilyst Medical, according to a news release.
AngioDynamics is a provider of minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology. Navilyst Medical focuses on technologies for the vascular system.
The transaction is valued at $355 million. The combination of the companies is expected to double AngioDynamics share of the vascular access market.
"Today is an important day for AngioDynamics' customers, shareholders and employees," said Joseph DeVivo, president and CEO of AngioDynamics, in the release. "We are a stronger and more competitive company as a result of scale, technology and talent gained by this acquisition. Our integration plan is underway and we are excited to begin creating the new AngioDynamics."
Related Articles on Company Acquisitions:
Cardinal Health to Acquire Dik Drug
Omnicell to Acquire MTS Medication Technologies
Ansell Completes Acquisition of Trelleborg Protective Products